From Genome Editing to Blastocyst Complementation: A new Horizon in Heart Transplantation?

Overview

Journal JTCVS Tech

Date 2022 Apr 11

PMID 35403039

Authors

Igor E Konstantinov

Gregory King

Enzo R Porrello

Affiliations

Soon will be listed here.

Citing Articles

Consensus statement on heart xenotransplantation in children: Toward clinical translation.

Konstantinov I, Cooper D, Adachi I, Bacha E, Bleiweis M, Chinnock R J Thorac Cardiovasc Surg. 2022; 166(3):960-967.

PMID: 36184321 PMC: 10124772. DOI: 10.1016/j.jtcvs.2022.09.001.

References

Gao L, Gregorich Z, Zhu W, Mattapally S, Oduk Y, Lou X . Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine. Circulation. 2017; 137(16):1712-1730. PMC: 5903991. DOI: 10.1161/CIRCULATIONAHA.117.030785. View

Sekine H, Shimizu T, Hobo K, Sekiya S, Yang J, Yamato M . Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation. 2008; 118(14 Suppl):S145-52. DOI: 10.1161/CIRCULATIONAHA.107.757286. View

Querdel E, Reinsch M, Castro L, Kose D, Bahr A, Reich S . Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner. Circulation. 2021; 143(20):1991-2006. PMC: 8126500. DOI: 10.1161/CIRCULATIONAHA.120.047904. View

Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S . Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. 2013; 494(7435):100-4. DOI: 10.1038/nature11807. View

Founta K, Papanayotou C . Generation of Organs by Blastocyst Complementation: Advances and Challenges. Int J Stem Cells. 2021; 15(2):113-121. PMC: 9148837. DOI: 10.15283/ijsc21122. View

Ronaldson-Bouchard K, Ma S, Yeager K, Chen T, Song L, Sirabella D . Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018; 556(7700):239-243. PMC: 5895513. DOI: 10.1038/s41586-018-0016-3. View

Castilho M, Feyen D, Flandes-Iparraguirre M, Hochleitner G, Groll J, Doevendans P . Melt Electrospinning Writing of Poly-Hydroxymethylglycolide-co-ε-Caprolactone-Based Scaffolds for Cardiac Tissue Engineering. Adv Healthc Mater. 2017; 6(18). PMC: 7116102. DOI: 10.1002/adhm.201700311. View

Vagnozzi R, Maillet M, Sargent M, Khalil H, Johansen A, Schwanekamp J . An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2019; 577(7790):405-409. PMC: 6962570. DOI: 10.1038/s41586-019-1802-2. View

Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, Landa N . Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A. 2009; 106(35):14990-5. PMC: 2736451. DOI: 10.1073/pnas.0812242106. View

10.

Gao L, Kupfer M, Jung J, Yang L, Zhang P, Sie Y . Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. Circ Res. 2017; 120(8):1318-1325. PMC: 5392171. DOI: 10.1161/CIRCRESAHA.116.310277. View

11.

Crane A, Shen F, Brown J, Cormack W, Ruiz-Estevez M, Voth J . The American Public Is Ready to Accept Human-Animal Chimera Research. Stem Cell Reports. 2020; 15(4):804-810. PMC: 7562947. DOI: 10.1016/j.stemcr.2020.08.018. View

12.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

13.

Lu T, Lin B, Kim J, Sullivan M, Tobita K, Salama G . Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun. 2013; 4:2307. DOI: 10.1038/ncomms3307. View

14.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

15.

Park S, Kim R, Park B, Lee S, Choi S, Park J . Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nat Commun. 2019; 10(1):3123. PMC: 6635499. DOI: 10.1038/s41467-019-11091-2. View

16.

Palpant N, Pabon L, Friedman C, Roberts M, Hadland B, Zaunbrecher R . Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells. Nat Protoc. 2016; 12(1):15-31. PMC: 5576871. DOI: 10.1038/nprot.2016.153. View

17.

Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A . Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Stem Cell Reports. 2016; 6(3):312-20. PMC: 4788782. DOI: 10.1016/j.stemcr.2016.01.012. View

18.

Tan T, Wu J, Si C, Dai S, Zhang Y, Sun N . Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo. Cell. 2021; 184(8):2020-2032.e14. DOI: 10.1016/j.cell.2021.03.020. View

19.

Balsam L, Wagers A, Christensen J, Kofidis T, Weissman I, Robbins R . Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428(6983):668-73. DOI: 10.1038/nature02460. View

20.

Guyette J, Charest J, Mills R, Jank B, Moser P, Gilpin S . Bioengineering Human Myocardium on Native Extracellular Matrix. Circ Res. 2015; 118(1):56-72. PMC: 4740234. DOI: 10.1161/CIRCRESAHA.115.306874. View